Apollo Health Ventures

New York, New York
Founded:2016
Firm Location:New York, New York • Boston, Massachusetts • Cambridge, Massachusetts • Berlin, Germany • Hamburg • Germany
Apollo Health Ventures Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Jan Adams, Venture Partner at Apollo Health Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Berlin (Germany)
Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
+8
n/a
$2.5M
($100K - $5.0M)
Investors in Berlin (Germany)
n/a
$1.5M
($100K - $5.0M)
Investors in Hamburg, Investors in Germany
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+1
n/a
$25K
($5K - $50K)
Investors in Berlin (Germany)
Investors in BioTech (Seed), Investors in BioTech (Pre-seed)
n/a
$1.5M
($100K - $5.0M)
Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed)
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in BioTech (Series B), Investors in BioTech (Series A)
Photo of Nils Regge, General Partner at Apollo Health Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Germany
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in New York (NY)
Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+8
n/a
$1.5M
($100K - $5.0M)
Investors in Berlin (Germany)
Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in Berlin (Germany)
Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
+1